Gamry Instruments is proud to be an exhibitor at Electrochemistry 2014, Basic Science and Key Technology for Future Applications
Online PR News – 13-September-2014 – Gamry Instruments, designer and manufacturer of electrochemical instruments, will be an exhibitor at Electrochemistry 2014 September 22-24, 2014 in Mainz, Germany. The meeting is being held at Johannes Gutenberg-Universitt.
Electrochemistry is a successful series of conferences, held every other year. Outstanding electrochemists from Germany and from abroad will highlight research results and current trends. Three parallel sessions will cover nearly all topics of electrochemistry from fundamental science to technical applications.
Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
Gamry Instruments will also be exhibiting in the chemistry department on campus of Johannes Gutenberg-Universitt Mainz.
Celebrating 25 years, Gamry was founded in 1989 designing and manufacturing precision electrochemical instruments and accessories. From the start, Gamry has created instruments with uncommon value and performance with the simple goal of wanting every user to be satisfied with their Gamry Instrument.
In addition to quality electrochemical instruments and cell design, Gamry takes pride in offering top notch support both before and after the sale. The sales and technical support staff consists of electrochemists and engineers with real-word research experience.
For more information on any of Gamrys electrochemical instruments, please contact Gamry Instruments at 215-682-9330 or email firstname.lastname@example.org.
You May Also Like
In the 15th Nov 2015 edition of Israel’s good news, the highlights include: · A new Israeli treatment brings hope to relapsed leukemia...